Gilead Sciences/ US3755581036 /
| 2025-03-17 7:59:59 PM | Chg. +0.84 | Volume | Bid2025-03-17 | Ask2025-03-17 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 112.26USD | +0.75% | 704,854 Turnover: 78.57 mill. |
112.16Bid Size: 100 | 112.33Ask Size: 100 | 139.8 bill.USD | 2.74% | 295.42 |
Assets
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 4,967 | 5,121 | 5,475 | 5,317 | 5,414 | ||||||
| Intangible Assets | 33,126 | 33,455 | 28,894 | 26,454 | 19,948 | ||||||
| Long-Term Investments | 502 | 1,309 | 1,245 | 1,163 | 0.0000 | ||||||
| Fixed Assets | 52,411 | 53,180 | 48,728 | 46,040 | 39,822 | ||||||
| Inventories | 1,683 | 1,618 | 1,507 | 1,787 | 1,710 | ||||||
| Accounts Receivable | 4,892 | 4,493 | 4,777 | 4,660 | 4,420 | ||||||
| Cash and Cash Equivalents | 5,997 | 5,338 | 5,412 | 6,085 | 9,991 | ||||||
| Current Assets | 15,996 | 14,772 | 14,443 | 16,085 | 19,173 | ||||||
| Total Assets | 68,407 | 67,952 | 63,171 | 62,125 | 58,995 | ||||||
Liabilities
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 844 | 705 | 905 | 550 | 833 | ||||||
| Long-term debt | 28,645 | 25,179 | 22,957 | 23,189 | 24,896 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 50,186 | 46,888 | 41,962 | 39,376 | 39,749 | ||||||
| Share Capital | 1 | 1 | 1 | 1 | 1 | ||||||
| Total Equity | 18,221 | 21,064 | 21,209 | 22,749 | 19,246 | ||||||
| Minority Interests | 19 | -5 | -31 | -84 | -84 | ||||||
| Total liabilities equity | 68,407 | 67,952 | 63,171 | 62,125 | 58,995 | ||||||
Income Statement
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 24,689 | 27,305 | 27,281 | 27,116 | 28,754 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 4,071 | 9,918 | 7,330 | 7,605 | 1,662 | ||||||
| Interest Income | -984 | -1,001 | -935 | -944 | -977 | ||||||
| Income Before Taxes | 1,669 | 8,278 | 5,814 | 6,859 | 690 | ||||||
| Income Taxes | 1,580 | -2,077 | -1,248 | -1,247 | 211 | ||||||
| Minority Interests Profit | -34 | 24 | 26 | 52 | 0.0000 | ||||||
| Net Income | 123 | 6,225 | 4,592 | 5,665 | 480 | ||||||
Per Share
Cash Flow
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 8,168 | 11,384 | 9,072 | 8,006 | 10,828 | ||||||
| Cash Flow from Investing Activities | -14,615 | -3,131 | -2,466 | -2,265 | -3,449 | ||||||
| Cash Flow from Financing | 770 | -8,877 | -6,469 | -5,125 | -3,433 | ||||||
| Decrease / Increase in Cash | -5,634 | -659 | 74 | 673 | 3,906 | ||||||
| Employees | 13,600 | 14,000 | - | - | - | ||||||
